Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Lisofylline enters pivotal testing for acute lung injury

Feb. 20, 1998

Independent evaluation committee requests additional OxSODrol data

Feb. 20, 1998

Enrollment complete in phase II trials for rPAF-AH

Feb. 20, 1998

Novel leukotriene antagonist with potential in asthma therapy

Feb. 19, 1998

New hope for patients diagnosed with malignant pleural effusions

Feb. 18, 1998

Klinge discovers compounds for asthma with high efficacy and safety

Feb. 18, 1998

Olopatadine still under regulatory review in Japan

Feb. 18, 1998

Substance P antagonists revealed by Boehringer Ingelheim

Feb. 18, 1998

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Feb. 17, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...